Keyword: MediCity

This page displays contents related to the keyword.

Professor of Practice Lecture - Timo Veromaa

Time

17.5.2021 at 15.00 - 16.30
Dr. Timo Veromaa has been appointed as Professor of Practice in Drug Development. The appointment strengthen the operations of the InFLAMES Flagship, joint effort of the University of Turku and Åbo Akademi University, funded by the Academy of Finland. The purpose of the professorship of practice in...

Professor of Practice Lecture - Juha Laine

Time

3.5.2021 at 15.00 - 16.30
Docent Juha Laine has been appointed as Professor of Practice in Pharmacoeconomics. The appointment strengthen the operations of the InFLAMES Flagship, joint effort of the University of Turku and Åbo Akademi University, funded by the Academy of Finland. The purpose behind the professorship of...

Missing BAP1 Gene Is Associated with Immunosuppressive Molecules in Uveal Melanoma

09.04.2020

New study from researchers in Finland and the United Kingdom reveals that tumors lacking a protein called BAP1 have an ineffective immune reaction against cancer, thus rendering immunotherapies ineffectual, particularly in uveal melanomas (UM). The researchers also discovered that when BAP1 is lost, other molecules will be present in order to support cancer growth. Luckily, some of these molecules can be targeted with existing drugs, which can lead to the development of novel immunotherapies.